Grifols S.A.

In News

Grifols Trial Could Expand Treatment Options for 60,000 Patients - Stock Titan

Stock Titan - Jul 16, 2026

Grifols, S.A. (GRFS) Stock Analysis: Exploring a Potential 49.45% Upside for Healthcare Investors - DirectorsTalk Interviews

DirectorsTalk Interviews - Jul 13, 2026

ETFs Investing in Grifols, S.A. Sponsored ADR Class B Stocks - TradingView

TradingView - Jul 10, 2026

Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo - Yahoo Finance

Yahoo Finance - Jun 02, 2026

Grifols sees core earnings rising by a quarter as it prioritises profitability - Reuters

Reuters - Feb 26, 2026

Grifols: Operational Recovery And Balance Sheet Improvement Support A Return To Buy (Rating Upgrade) - Seeking Alpha

Seeking Alpha - Jul 03, 2026

Grifols S.A. (GRFS) Releases Q4 2025 Earnings: Revenue Up Strongly but EPS and Cash Flow Slump - Quiver Quantitative

Quiver Quantitative - Feb 26, 2026

Osborne Clarke advises Grifols, S.A. on the refinancing of its capital structure - Osborne Clarke

Osborne Clarke - May 06, 2026

Grifols Aims to Raise Up to $5 Billion in IPO of US Unit - Bloomberg.com

Bloomberg.com - Mar 25, 2026

Price to earnings forward of Grifols, S.A. Class A – BME:GRF - TradingView

TradingView - Jul 07, 2026

Health Canada Imposes New Conditions on Grifols, S.A. (GRFS) Plasma Collection Centers - Yahoo Finance

Yahoo Finance - Apr 17, 2026

Grifols approves IPO of its US biopharma business - Reuters

Reuters - Mar 24, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment